Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 181-192 of 2,031
Device study icon
RecruitingNCT06085950

Transcranial Ultrasonic Stimulation for treatment-resistant depression

This study is recruiting in France. It is testing transcranial Ultrasonic Stimulation for treatment-resistant depression.

In Paris
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 75 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Depression
Device study icon
RecruitingNCT05798143

Translational Biomarkers in Accelerated Neuromodulation for Treatment-resistant Depression

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants take part in the program and complete follow-up questionnaires or assessments.

In Chieti
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 65 Years
Countries
Italy
Sponsor
ITAB - Institute for Advanced Biomedical Technologies
Condition
Depression
Device study icon
RecruitingNCT06423430

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

This study is looking at whether Sham-stimulation can help people with Treatment Resistant Depression. Participants take part in Sham-stimulation and complete follow-up assessments.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
Abbott Medical Devices
Condition
Depression
Other study type icon
RecruitingISRCTN45842879

The CASPER-PLUS study: collaborative care in screen positive elders with major depressive disorder

This study is looking at whether a digital support tool can help people with Depression / mental well-being, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
United Kingdom
Sponsor
University of York (UK)
Condition
Depression
Drug study icon
RecruitingNCT06236880

Safety study of GM-2505 in Depression

This study is recruiting in the United Kingdom. It is testing GM-2505 for Depression.

In Manchester
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Gilgamesh Pharmaceuticals
Condition
Depression
Drug study icon
RecruitingNCT07300969

Effectiveness of DT-101 in depression

This study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing DT-101 for depression.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Draig Therapeutics Ltd
Condition
Depression
Behavioral study icon
RecruitingNCT07025720

Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide prevention

This study is looking at whether TMS can help people with depression or Suicide prevention. Participants receive a study treatment and complete follow-up visits and assessments.

In Sacramento
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityBehavioralFrom 15 Years to 25 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Depression, Suicidality
Device study icon
RecruitingNCT07212465

Accelerated Neuromodulation of Anterior Cingulate Cortex for Depression

This study is comparing Active Brainsway H7-Coil Deep TMS System with 20-40 sessions of sham stimulation for people with depression. Participants receive Active Brainsway H7-Coil Deep TMS System or 20-40 sessions of sham stimulation and complete study visits and assessments.

In Toronto
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 60 Years to 85 Years
Countries
Canada
Sponsor
Rotman Research Institute at Baycrest
Condition
Depression
Device study icon
RecruitingNCT07115628

Accelerated TMS for Treatment-Resistant ECT

This study is looking at whether Transcranial Magnetic Stimulation can help people with depression. Participants take part in Transcranial Magnetic Stimulation and complete follow-up assessments.

In Jette
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 70 Years
Countries
Belgium
Sponsor
Universitair Ziekenhuis Brussel
Condition
Depression
Drug study icon
RecruitingNCT07479758

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

This study is recruiting in China. It focuses on Depression.

In Hangzhou
Why is this study shown?

This study is directly about Depression.

Depression, Schizophrenia, ...OtherFrom 18 Years to 45 Years
Countries
China
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Condition
Depression, Schizophrenia, ...
Device study icon
RecruitingNCT07217444

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

This observational study is following people with depression, Suicide prevention, or Hospitalization in Children to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Cincinnati
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDeviceFrom 14 Years to 18 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
Depression, Suicidality
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.